{
  "created_at": "Thu Jul 29 5:41:59 +0000 2021",
  "id_str": "1420585761162678275",
  "full_text": "CORONAVIRUS: Pfizer study shows that third dose of coronavirus vaccine is associated with a five-fold increase in antibodies in those aged 18-55 and an eleven-fold increase in those aged 65-85.",
  "display_text_range": [
    0,
    193
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": []
  },
  "user": {
    "name": "The Spectator Index",
    "screen_name": "spectatorindex",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1145865652533547008/XBahoZmX_normal.png"
  },
  "retweet_count": 771,
  "favorite_count": 2941,
  "original_created_at": "Thu Jul 29 03:23:33 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "CORONAVIRUS: ファイザー社の研究によると、コロナウイルスワクチンの3回目の接種は、18～55歳では5倍、65～85歳では11倍の抗体の増加に関連しています。"
    },
    {
      "locale": "zh",
      "full_text": "CORONAVIRUS: 辉瑞公司的研究表明，第三剂冠状病毒疫苗与18-55岁人群的抗体增加5倍和65-85岁人群的抗体增加11倍有关。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "CORONAVIRUS: 輝瑞公司的研究表明，第三劑冠狀病毒疫苗與18-55歲人羣的抗體增加5倍和65-85歲人羣的抗體增加11倍有關。"
    }
  ]
}